SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-028165
Filing Date
2021-05-17
Accepted
2021-05-17 07:05:20
Documents
17
Period of Report
2021-05-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alt-8k_20210517.htm 8-K 38991
2 EX-99.1 alt-ex991_6.htm EX-99.1 256026
3 EX-99.2 alt-ex992_100.htm EX-99.2 10782
4 GRAPHIC slide-gvt2bojrirm.jpg GRAPHIC 458215
5 GRAPHIC slide-gleq022r20u.jpg GRAPHIC 234238
6 GRAPHIC slide-12khq0kmwql.jpg GRAPHIC 126351
7 GRAPHIC slide-m5kty55stfu.jpg GRAPHIC 137278
8 GRAPHIC slide-u4ztzsoyar2.jpg GRAPHIC 130228
9 GRAPHIC slide-1k2rxeirphm.jpg GRAPHIC 128361
10 GRAPHIC slide-2yu533ltnwv.jpg GRAPHIC 194233
11 GRAPHIC gly2dlcud2ak000001.jpg GRAPHIC 8685
12 GRAPHIC slide-qo4ofkj11jn.jpg GRAPHIC 234238
13 GRAPHIC slide-2xgnzqd210z.jpg GRAPHIC 148271
14 GRAPHIC slide-mzgo2n0dpec.jpg GRAPHIC 178218
15 GRAPHIC slide-3kbij21ucix.jpg GRAPHIC 253404
16 GRAPHIC slide-2o0atedfig3.jpg GRAPHIC 140936
17 GRAPHIC slide-zofp2mrvnns.jpg GRAPHIC 205445
  Complete submission text file 0001564590-21-028165.txt   3859915
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 21927502
SIC: 2834 Pharmaceutical Preparations